Achievement of Goals in U.S. Diabetes Care, 1999–2010
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tracking national progress in diabetes care may aid in the evaluation of past efforts and identify residual gaps in care. METHODS: We analyzed data for adults with self-reported diabetes from the National Health and Nutrition Examination Survey and the Behavioral Risk Factor Surveillance System to examine risk-factor control, preventive practices, and risk scores for coronary heart disease over the 1999-2010 period. RESULTS: From 1999 through 2010, the weighted proportion of survey participants who met recommended goals for diabetes care increased, by 7.9 percentage points (95% confidence interval [CI], 0.8 to 15.0) for glycemic control (glycated hemoglobin level <7.0%), 9.4 percentage points (95% CI, 3.0 to 15.8) for individualized glycemic targets, 11.7 percentage points (95% CI, 5.7 to 17.7) for blood pressure (target, <130/80 mm Hg), and 20.8 percentage points (95% CI, 11.6 to 30.0) for lipid levels (target level of low-density lipoprotein [LDL] cholesterol, <100 mg per deciliter [2.6 mmol per liter]). Tobacco use did not change significantly, but the 10-year probability of coronary heart disease decreased by 2.8 to 3.7 percentage points. However, 33.4 to 48.7% of persons with diabetes still did not meet the targets for glycemic control, blood pressure, or LDL cholesterol level. Only 14.3% met the targets for all three of these measures and for tobacco use. Adherence to the recommendations for annual eye and dental examinations was unchanged, but annual lipid-level measurement and foot examination increased by 5.5 percentage points (95% CI, 1.6 to 9.4) and 6.8 percentage points (95% CI, 4.8 to 8.8), respectively. Annual vaccination for influenza and receipt of pneumococcal vaccination for participants 65 years of age or older rose by 4.5 percentage points (95% CI, 0.8 to 8.2) and 6.9 percentage points (95% CI, 3.4 to 10.4), respectively, and daily glucose monitoring increased by 12.7 percentage points (95% CI, 10.3 to 15.1). CONCLUSIONS: Although there were improvements in risk-factor control and adherence to preventive practices from 1999 to 2010, tobacco use remained high, and almost half of U.S. adults with diabetes did not meet the recommended goals for diabetes care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Still, many do not meet the recommended goals for diabetes care [7-9]; in Norway, research has shown that only 20% attain the target for metabolic control for glycated hemoglobin A1c (HbA1c), blood pressure, and lipid level, although the quality of care has improved [8].”
In the citing paper
“there is evidence that measures of 10-year CHD risk among U.S. adults with diabetes have improved signi fi cantly over the past decade (2)”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [2]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Research works printed but not linked: 2
- Ahmann AJ, 2007, Am J Manag Care, 13, S41
- Gary TL, 2003, Ethn Dis, 13, 47
Cited by
Items 401–500 of 978
Al-Rowais, N. A. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.06.008 · Cited by 22
“adults with diabetes did not meet the recommended goals for diabetes care (Ali et al., 2013).”
Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
Miñambres, I., Mediavilla, J., Sarroca, J., & Pérez, A. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0090-1 · Cited by 21
“equately controlled if a universal HbA1c target of <7 % (53 mmol/mol) was applied, compared with 30 % if using individualized ADA glycemic targets [6, 7].”
MethodYeung, R. O., Cai, J., Zhang, Y., Luk, A. O. Y., Pan, J., Yin, J., Ozaki, R., Kong, A. P. S., Ronald, C. W., So, W., et al. (2018) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-018-0055-6 · Cited by 20
“In the United States, less than half of the patients have attained recommended goals for diabetes care [1].”
BackgroundPaes, V. M., Barrett, J., Taylor-Robinson, D. C., Chesters, H., Charalampopoulos, D., Dunger, D. B., Viner, R., & Stephenson, T. J. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12850 · Cited by 29
Gori, M., Lam, C. S. P., D’Elia, E., Iorio, A. M., Calabrese, A., Canova, P. A., Cioffi, G., Maria, R. D., Ghirardi, A., Iacovoni, A., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319899618 · Cited by 20
Does Knowing One’s Elevated Glycemic Status Make a Difference in Macronutrient Intake?
Bardenheier, B. H., Cogswell, M. E., Gregg, E. W., Williams, D. E., Zhang, Z., & Geiss, L. S. (2014) · Diabetes Care · doi:10.2337/dc14-1342 · Cited by 20
“However, national data indicate that only one-half of people with diabetes report ever receiving some type of diabetes education (2), and possibly even fewer see an RD.”
BackgroundSelf-citationThe State of Diabetes Prevention Policy in the USA Following the Affordable Care Act
Konchak, J. N., Moran, M. R., O’Brien, M. J., Kandula, N. R., & Ackermann, R. T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0742-6 · Cited by 26
“Another potential gap is that neither health insurance coverage nor clinical practice recommendations are sufficient to ensure that screening and detection occur routinely [57].”
Peng, Y. H., Chang, Q., Yang, N., Gu, S., Zhou, Y., Yin, L., Aa, J., Wang, G., & Sun, J. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.02.007 · Cited by 20
Mortality in Type 1 Diabetes in the Current Era: Two Steps Forward, One Step Backward
Katz, M. L., & Laffel, L. M. (2015) · JAMA · doi:10.1001/jama.2014.16327 · Cited by 26
Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
Jung, J.-H., Lee, J. H., Noh, J., Park, J.-E., Kim, H. S., Yoo, J. W., Song, B.-R., Lee, J.-R., Hong, M.-H., Jang, H.-M., et al. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.4.307 · Cited by 19
Souliotis, K. N., Koutsovasilis, A., Vatheia, G., Golna, C., Nikolaidi, S., Hatziagelaki, E. E., Kotsa, K., Koufakis, T., Melidonis, A. J., Papazafiropoulou, A. K., et al. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0496-7 · Cited by 25
Cai, C., Liu, Y., Li, Y., Shi, Y., Zou, H., Bao, Y., Shen, Y., Cui, X., Fu, C., Jia, W., et al. (2021) · Frontiers of Medicine · doi:10.1007/s11684-021-0897-7 · Cited by 19
Yokoyama, H., Araki, S., Yamazaki, K., Kawai, K., Shirabe, S., Oishi, M., Kanatsuka, A., Yagi, N., Kabata, D., Shintani, A., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002727 · Cited by 21
Diabetes And The Fragmented State Of US Health Care And Policy
Chehal, P. K., Selvin, E., DeVoe, J. E., Mangione, C. M., & Ali, M. K. (2022) · Health Affairs · doi:10.1377/hlthaff.2022.00299 · Cited by 24
Self-citationCould Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review
Alonso-Carril, N., Rodriguez-Rodríguez, S., Quirós, C., Berrocal, B., Amor, A. J., Barahona, M. J., Martínez, D., Ferré, C., & Perea, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01595-6 · Cited by 21
“Compared with people with T1D, those with T2D were older and less likely to receive diabetes education [58].”
News from the NIH: research to evaluate “natural experiments” related to obesity and diabetes
Hunter, C. M., McKinnon, R. A., & Esposito, L. E. (2014) · Translational Behavioral Medicine · doi:10.1007/s13142-013-0250-z · Cited by 20
“Further, most adults with diabetes in the USA are not meeting the recommended goals for diabetes care [7].”
BackgroundEmpagliflozin/Linagliptin: A Review in Type 2 Diabetes
Kim, E., & Deeks, E. D. (2015) · Drugs · doi:10.1007/s40265-015-0457-z · Cited by 20
Sohler, N., Matti‐Orozco, B., Young, E., Li, X., Gregg, E. W., Ali, M. K., Bullard, K. M., & Albu, J. (2015) · Endocrine Practice · doi:10.4158/ep15866.or · Cited by 23
Self-citationLiu, X., Wang, L., Wang, P., Liu, R., Yang, K., Qian, X., Fan, J., Yu, S., Li, Y., & Wang, C. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9092759 · Cited by 19
RetractedThe Real-Life Effectiveness and Care Patterns of Type 2 Diabetes Management in Greece
Pagkalos, E. M., Thanopoulou, A. C., Sampanis, C., Bousboulas, S., Melidonis, A. J., Tentolouris, N., Alexandrides, T. K., Migdalis, I. N., Karamousouli, E., & Παπάνας, Ν. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-109242 · Cited by 20
The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes
Pasquel, F. J., Gregg, E. W., & Ali, M. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.11.001 · Cited by 21
Self-citationPawaskar, M. D., Xu, L., Tang, Y., Puckrein, G. A., Rajpathak, S. N., & Stuart, B. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0489-y · Cited by 21
Lee, J.-Y., Cho, Y., Lee, M., Kim, Y. J., Lee, Y., Lee, B., Soo, B., & Kang, E. S. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0057 · Cited by 21
Predictors of mortality among patients with type 2 diabetes in Jordan
Mayyas, F., & Ibrahim, K. S. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00866-8 · Cited by 19
Inequalities in care for the people with diabetes in Brazil: A nationwide study, 2019
Neves, R. G., Saes, M. D. O., Duro, S. M. S., Flores, T. R., & Tomasi, E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270027 · Cited by 22
“These tests can and should be performed during routine appointments, as recommended by national and international guidelines for disease control [2, 6, 31], and are important indicators of quality of care for individuals with DM and preventing the onset of disabilities and irreversible blindness [32].”
BackgroundKing, A., RAJPURA, J. R., Liang, Y. M., Paprocki, Y., & Uzoigwe, C. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2125259 · Cited by 21
Lim, S. K., Sohn, M., Florez, J. C., Nauck, M. A., & Ahn, J. (2023) · Nutrients · doi:10.3390/nu15010248 · Cited by 20
“0% (53 mmol/mol), indicating that there is an unmet medical need for more optimal glycemic diabetes management [1].”
Hashemi‐Madani, N., Ismail‐Beigi, F., Khamseh, M. E., Malek, M., & Valojerdi, A. E. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317707293 · Cited by 19
Williams, J. S., Bishu, K. G., Germain, A. S., & Egede, L. E. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0183-5 · Cited by 20
Bode, B. W., Clarke, J. G., & Johnson, J. M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747886 · Cited by 19
“Even with the introduction of dozens of medications to the market,(4) the percentage of patients with an A1C above 9% and the percentage of patients not at A1C goal has changed little in the last decade.(5-7) Thus, technology is needed to help patients better self-manage their diabetes using basal and bolus insulin th…”
BackgroundTanaka, H., Sugiyama, T., Ihana‐Sugiyama, N., Ueki, K., Kobayashi, Y., & Ohsugi, M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.02.001 · Cited by 18
Zhang, J., Li, L., Liu, C., Li, P., & Yu, C. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000146 · Cited by 21
“The studies met the following criteria were included: [1] RCTs recruited adult patients of T2DM with inadequate glycemic control on metformin, [2] Studies compared SGLT2-i as add-on to metformin with placebo combined with metformin, [3] Treatment duration ≥ 12 weeks, [4] The following data was completely reported: the…”
MethodLangholz, P. L., Wilsgaard, T., Njølstad, I., Jorde, R., & Hopstock, L. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041846 · Cited by 21
Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study
Milani, R. V., Chava, P., Wilt, J. K., Entwisle, J., Karam, S., Burton, J. H., & Blonde, L. (2021) · JMIR Diabetes · doi:10.2196/24687 · Cited by 20
“Although progress has been made to improve risk factors for microvascular and macrovascular disease in diabetes, approximately half of individuals with diabetes do not meet individualized targets for HbA1c, and less than 15% meet all three targets of glycemic control, blood pressure, and low-density lipoprotein (LDL)…”
BackgroundFeng, L., Lam, A. Y. R., Carmody, D., Lim, C. W., Tan, G. C. S., Goh, S., Bee, Y. M., & Jafar, T. H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259157 · Cited by 19
Age at diagnosis of type 2 diabetes and cardiovascular risk factor profile: A pooled analysis
Barker, M. M., Zaccardi, F., Brady, E. M., Gulsin, G. S., Hall, A. P., Henson, J., Htike, Z. Z., Khunti, K., McCann, G. P., Redman, E. L., et al. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.260 · Cited by 19
Baek, H.-S., Park, J., Yu, J. S., Lee, J., Yang, Y., Ha, J., Lee, S., Cho, J., Lim, D., & Kim, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1501 · Cited by 24
“Lastly, research also suggests that younger patients had lower rates of reaching glycemic control targets [26].”
ResultKalra, S., Das, A. K., Baruah, M. P., Unnikrishnan, A., Dasgupta, A., Shah, P., Sahay, R. K., Shukla, R., Das, S., TIWASKAR, M. H., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0651-1 · Cited by 18
Alkandari, A., Vaucher, J., & Marques-Vidal, P. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003377 · Cited by 15
Ma, S., Zhang, M., Sun, W., Gao, Y., Jing, M., Gao, L., & Wu, Z. (2025) · Healthcare and Rehabilitation · doi:10.1016/j.hcr.2024.100006 · Cited by 23
“4,5 Therefore, it is essential to utilize technological means to assist healthcare professionals in managing diabetes.”
Internet Blood Glucose Monitoring Systems Provide Lasting Glycemic Benefit in Type 1 and 2 Diabetes
Tildesley, H. D., Po, M. D., & Ross, S. A. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.08.019 · Cited by 20
Differences in the Triglyceride to HDL-Cholesterol Ratio between Palestinian and Israeli Adults
Weiss, R., Nassar, H., Sinnreich, R., & Kark, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116617 · Cited by 17
“The Middle East is also affected by alarming increases in the prevalence of obesity both in children and adults and of diabetes which have been documented in several Arab countries [3, 4].”
BackgroundNelson, K. M., Drain, N., Robinson, J., Kapp, J., Hebert, P. L., Taylor, L., Silverman, J. B., Kiefer, M. M., Lessler, D., & Krieger, J. W. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.06.011 · Cited by 20
“[6] Thus, translating effective interventions into diverse community settings to address these unique needs remains a public health challenge.[7]”
BackgroundElectrical stimulation of renal nerves for modulating urine glucose excretion in rats
Jiman, A. A., Chhabra, K. H., Lewis, A. G., Cederna, P. S., Seeley, R. J., Low, M. J., & Bruns, T. M. (2018) · Bioelectronic Medicine · doi:10.1186/s42234-018-0008-5 · Cited by 18
“Despite the progress in the development of diabetic medications, many lose their effectiveness over time, which makes achieving blood glucose control targets difficult for many diabetic patients (Blak et al. 2012; Khunti et al. 2013; Ali et al. 2013).”
BackgroundGori, M., Redfield, M. M., Calabrese, A., Canova, P. A., Cioffi, G., Maria, R. D., Grosu, A., Fontana, A., Iacovoni, A., Ferrari, P., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1298 · Cited by 17
“Atrial fibrillation 21 (3) 10 (2) 11 (8) 0.”
McElfish, P. A., Rowland, B., Riklon, S., Aitaoto, N., Sinclair, K., Ima, S., Kadlubar, S. A., Goulden, P., Hudson, J. S., Mamis, S., et al. (2019) · Policy Politics & Nursing Practice · doi:10.1177/1527154419872834 · Cited by 18
“However, rates of self-management behaviors and glycemic control are low in the general T2DM patient population (Ali et al., 2013), and even lower in many racial and ethnic minority groups (Campbell, Walker, Smalls, & Egede, 2012; Harris, Eastman, Cowie, Flegal, & Eberhardt, 1999; Karter, Ferrara, Darbinian, Ackerson,…”
BackgroundMosley-Johnson, E., Walker, R. J., Nagavally, S., Hawks, L. C., Bhandari, S., Trasser, H., Campbell, J. A., & Egede, L. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278650 · Cited by 17
“In addition, gaps in diabetes care are especially persistent for nonwhite adults with diabetes, with only 14% of Non-Hispanic Blacks and 18% of Hispanics achieving the recommended treatment goals compared to 25% of Non-Hispanic Whites [4, 5].”
BackgroundAre You Ready for More Insulin Concentrations?
Segal, A. R., & ElSayed, N. A. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814557860 · Cited by 16
“Almost half of US adults with diabetes did not meet the recommended goals for diabetes care.(3) New concentrated insulins will add tools to tailor insulin regimens for patients who require large daily doses or for use in administration devices (insulin pumps or artificial pancreas) with smaller reservoirs than current…”
BackgroundLafata, J. E., Karter, A. J., O’Connor, P. J., Morris, H., Schmittdiel, J. A., Ratliff, S. M., Newton, K. M., Raebel, M. A., Pathak, R. D., Thomas, A., et al. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3486-0 · Cited by 17
Peterson, L. E., Blackburn, B. E., Phillips, R. L., & Puffer, J. C. (2014) · Journal of Continuing Education in the Health Professions · doi:10.1002/chp.21216 · Cited by 16
“Quality measures used in the PPM were National Quality Forum (NQF) endorsed and included (1) foot examination, (2) assessment of the presence of microalbuminuria, (3) hemoglobin A1c measurement, (4) blood pressure measurement, (5) smoking cessation counseling for smokers, (6) retina examination, and (7) low-density li…”
BackgroundMethodQuality improvement in diabetes—successful in achieving better care with hopes for prevention
HAW, J. S., Narayan, K. M. V., & Ali, M. K. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12950 · Cited by 17
Self-citationChristine, P. J., Young, R. L., Adar, S. D., Bertoni, A. G., Heisler, M., Carnethon, M. R., Hayward, R. A., & Roux, A. V. D. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.04.019 · Cited by 20
“Using a large, multi-ethnic, prospective cohort, this study investigates if adding individualand area-level SES to traditional risk prediction models: (1) aids in the discrimination of people who developed diabetes from those who remained diabetes free; (2) improves prediction accuracy (i.”
BackgroundKazemian, P., Wexler, D. J., Fields, N. F., Parker, R. A., Zheng, A., & Walensky, R. P. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0393 · Cited by 18
Diabetes Distress: Assessment and Management of the Emotional Aspect of Diabetes Mellitus
Rariden, C. A. (2019) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2019.06.020 · Cited by 20
Chang, L., Vaduganathan, M., Plutzky, J., & Aroda, V. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1260-0 · Cited by 17
Castellana, M., Procino, F., Sardone, R., Trimboli, P., & Giannelli, G. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001477 · Cited by 19
Malekzadeh, H., Lotfaliany, M., Ostovar, A., Hadaegh, F., Azizi, F., Yoosefi, M., Farzadfar, F., & Khalili, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-68640-9 · Cited by 19
Phillips, S. E., Culpepper, J., Welch, M., O’Hare, K., Chen, W., Taylor, Y. J., Anderson, W. B., & Tapp, H. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.03.200307 · Cited by 19
Fraze, T., Lewis, V. A., Tierney, E., & Colla, C. H. (2017) · Population Health Management · doi:10.1089/pop.2017.0102 · Cited by 18
“To be optimally controlled, persons with diabetes must manage their blood sugar, cholesterol, blood pressure, and avoid tobacco products(4); however, only approximately 14% of adults with diabetes are optimally controlled across these metrics.(14) Research has shown that health care organizations, and especially prima…”
BackgroundOn behalf of the NEXT-D Study Group, Ali, M. K., Wharam, J. F., Duru, O. K., Schmittdiel, J. A., Ackermann, R. T., Albu, J., Ross‐Degnan, D., Hunter, C. M., Mangione, C. M., et al. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1112-3 · Cited by 16
Self-citationChina’s Burgeoning Epidemic of Diabetes-Associated Mortality
Chan, M. (2017) · JAMA · doi:10.1001/jama.2016.19736 · Cited by 20
Weir, M. R. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15764 · Cited by 18
Threatt, T. B., & Ward, E. D. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.019 · Cited by 15
Advancing Measurement of Diabetes at the Population Level
Ali, M. K., Siegel, K. R., Laxy, M., & Gregg, E. W. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1088-z · Cited by 15
Self-citationUsing Flash Continuous Glucose Monitoring in Primary Practice
Hirsch, I. B., & Wright, E. E. (2018) · Clinical Diabetes · doi:10.2337/cd18-0054 · Cited by 15
Patoulias, D., Katsimardou, A., Kalogirou, M., Zografou, I., Toumpourleka, M., Imprialos, K. P., Stavropoulos, K., Stergiou, I., Papadopoulos, C. E., & Doumas, M. N. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.04.001 · Cited by 15
Slåtsve, K. B., Claudi, T., Lappegård, K. T., Jenum, A. K., Larsen, M., Cooper, J. G., Sandberg, S., & Berg, T. J. (2020) · Scandinavian Journal of Public Health · doi:10.1177/1403494820951004 · Cited by 16
“[23] Ali MK, Bullard KM, Saaddine JB, et al.”
BackgroundFirkus, D. M., McCoy, R. G., Matulis, J. C., Kessler, M., Mara, K. C., & Herges, J. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280654 · Cited by 16
Analysis of the efficacy of SGLT2 inhibitors using semi-mechanistic model
Demin, O. O., Yakovleva, T. A., Kolobkov, D., & Demin, O. O. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00218 · Cited by 16
“However, in clinical practice patients often fail to meet the targets for glycemic control (Ali et al., 2013), most frequently because of adverse effects–including hypoglycemia and weight gain–caused by therapeutic agents (Neumiller, 2014).”
BackgroundMcAlister, F. A., Youngson, E. R. E., & Eurich, D. T. (2016) · Medicine · doi:10.1097/md.0000000000003894 · Cited by 20
Linetzky, B., Curtis, B. H., Frechtel, G. D., Montenegro, R. M., Escalante-Pulido, M., Stempa, O., de Lana, J. M., & Gagliardino, J. J. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0157-1 · Cited by 16
Sohn, M., Kang, H., Park, J. S., Yates, P., McCall, A. L., Stukenborg, G. J., Anderson, R. T., Balkrishnan, R., & Lobo, J. M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000284 · Cited by 15
Buysman, E. K., Anderson, A. J., Bacchus, S., & Ingham, M. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0500-4 · Cited by 18
LaFata, E. M., Tuerk, P. W., Wadden, T. A., Garvey, W. T., Weiß, D., Hermayer, K. L., Aronne, L. J., Becker, L. E., Fujioka, K., Miller‐Kovach, K., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0530-x · Cited by 19
“The SC intervention represented diabetes education typically provided to persons with T2DM [19, 20], rather than standardizing the frequency and duration of contact with treatment providers in the WW condition.”
Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19
Agarwal, S., Griffith, M. L., Murphy, E. J., Greenlee, C. M., Boord, J. B., & Gabbay, R. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa704 · Cited by 17
“Barriers include: (1) lack of generalizable payment models; (2) slow technology integration into health care; (3) real-world implementation challenges; (4) a dearth of rigorous outcomes and cost data; (5) workforce shortages from burnout; and (6) no infrastructure for sustainability of innovative models.”
BackgroundEmerging technologies for the management of type 2 diabetes mellitus
Shah, N. A., & Levy, C. J. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13188 · Cited by 18
“Despite this significant cost burden, only 50% of patients achieve a goal glycosylated hemoglobin (HbA1c) <7%,(4) which has been shown to reduce morbidity and mortality.(5,6) Moreover, optimal glycemic control in diabetes is no longer defined just by target HbA1c levels, which provide only an “average glucose level.”
BackgroundThe Burden of Diabetes Mortality by County, Race, and Ethnicity in the U.S., 2000–2019
Nassereldine, H., Li, Z., Compton, K., Kendrick, P., Kahn, E., Kelly, Y. O., Baumann, M. M., Schmidt, C. A., Sylte, D. O., Ong, K. L., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2259 · Cited by 17
“Improved management of type 1 and type 2 diabetes is likely an important factor in the declines in diabetes mortality rates observed across all racial and ethnic populations and most counties from 2005 to 2013 (19).”
Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus
Berg, D. D., Moura, F. A., Bellavia, A., Scirica, B. M., Wiviott, S. D., Bhatt, D. L., Raz, I., Bohula, E. A., Giugliano, R. P., Park, J., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.031 · Cited by 14
Understanding the Type 2 Diabetes Mellitus and Cardiovascular Disease Risk Paradox
Green, J. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2767 · Cited by 16
Janghorbani, M., Papi, B., & Amini, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12349 · Cited by 14
Leiter, L. A., Shestakova, M. V., Trubitsyna, N. P., Piletič, M., & Satman, İ. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.001 · Cited by 14
The Role of Occupational Therapy in Secondary Prevention of Diabetes
Shen, X., & Shen, X. (2019) · International Journal of Endocrinology · doi:10.1155/2019/3424727 · Cited by 16
Nkomani, S., Rusakaniko, S., & Blaauw, R. (2019) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2019.1641272 · Cited by 18
“18 It must be noted that the scope and content of DSME interventions in most Zimbabwean clinics are not documented, nor do standards for DSME exist.”
BackgroundMustonen, E., Hörhammer, I., Absetz, P., Patja, K., Lammintakanen, J., Talja, M. T., Kuronen, R., & Linna, M. (2019) · Health Services Research · doi:10.1111/1475-6773.13251 · Cited by 22
Peng, X., Ayyagari, R., LUBWAMA, R. N., Shi, L., Price‐Haywood, E. G., Hollander, P. A., & Fonseca, V. A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00783-4 · Cited by 15
Marshall, C. J., Rodriguez, H. P., Dyer, W., & Schmittdiel, J. A. (2020) · Women's Health Issues · doi:10.1016/j.whi.2020.03.003 · Cited by 14
Lv, Q., Shen, J., Miao, L., Ye, B., Schepers, C., Plat, A. W., & Shi, Y. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00819-9 · Cited by 16
Patel, K., Gomes, M. B., Charbonnel, B. H., Chen, H., Cid‐Ruzafa, J., Fenici, P., Hammar, N., Ji, L., Kennedy, K. F., Khunti, K., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14180 · Cited by 17
“In a post hoc analysis of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with diabetes and ASCVD, there was a stepwise decrease in the risk of the composite of myocardial infarction, stroke, or cardiovascular death over a median of 3 years of follow-up with each cardiovascular risk f…”
BackgroundInfluentialGabler, M., Picker, N., Geier, S., Ley, L., Aberle, J., Lehrke, M., Martin, S., Riedl, M., & Wilke, T. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01024-y · Cited by 14
Evaluation of an Enhanced Primary Care Team Model to Improve Diabetes Care
Herges, J. R., Matulis, J. C., Kessler, M., RUEHMANN, L. L., Mara, K. C., & McCoy, R. G. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2884 · Cited by 15
Peyrot, M. F., Egede, L. E., Funnell, M. M., Hsu, W. C., Ruggiero, L., Siminerio, L. M., & Stuckey, H. L. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1043251 · Cited by 14
“Risk/ protective factors examined are organized into five categories: (1) demographic characteristics of family members (gender, age, income, work status, non-diabetes daily obligations); (2) demographic characteristics of the person with diabetes (relationship to family member, age, gender) and diabetes (injection tr…”
BackgroundMethodQuality Indicators and Performance Measures in Diabetes Care
Aron, D. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0472-y · Cited by 16
Understanding the Meaning of Food in People With Type 2 Diabetes Living in Northern Appalachia
Beverly, E. A., Ritholz, M. D., Wray, L. A., Chiu, C., & Suhl, E. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0059 · Cited by 19
“Unfortunately, only half of diabetes patients receive diabetes education, and even fewer receive education from a dietitian or nutritionist (64).”
BackgroundDiabetes and Mortality in Acute Coronary Syndrome: Findings from the Gulf COAST Registry
Shehab, A., Bhagavathula, A. S., Al‐Rasadi, K., Alshamsi, F. E., Alkaabi, J., Thani, K. B., & Mustafa, R. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666181024094337 · Cited by 14
Nair, D. R., Satheesh, K., Raghavan, A., Nanditha, A., Vinitha, R., Susairaj, P., Snehalatha, C., & Ramachandran, A. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.018 · Cited by 14
Lithovius, R., Harjutsalo, V., Forsblom, C. M., Saraheimo, M., & Groop, P. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0595-x · Cited by 14
Ribeiro, R. T., Andrade, R., Nascimento do Ó, D., Lopes, A. F., & Raposo, J. F. (2021) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.024 · Cited by 13
Kawano, Y., Takemoto, M., Mito, T., Morisaki, H., Tanaka, A., Sakaki, Y., Matsuo, A., Abe, K., Hida, S., Mukae, K., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.008 · Cited by 16
Redesigning Diabetes Care: Defining the Role of Endocrinologists Among Alternative Providers
Malkani, S., Keitz, S. A., & Harlan, D. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0818-3 · Cited by 13
Lin, L.-C., Lee, L.-C., Huang, C., Chen, C.-T., Song, J., Shiao, Y., & Liu, H. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152946 · Cited by 13
Metadata
- Authors
- Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W.
- Affiliations
- Centers for Disease Control and Prevention (US)
- National Institutes of Health (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-04-25
- Volume
- 368
- Issue
- 17
- Pages
- 1613-1624
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2124234371
- Cited by
- 979
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 31 · 2023: 45 · 2022: 57 · 2021: 61 · 2020: 77 · 2019: 106 · 2018: 98 · 2017: 112 · 2016: 106 · 2015: 112 · 2014: 97 · 2013: 33
- FWCI
- 91.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes management, glycemic control, HbA1c, blood pressure control, LDL cholesterol, tobacco use, coronary heart disease risk, preventive medicine, annual eye examination, foot examination, influenza vaccination, pneumococcal vaccination, self-monitoring of blood glucose, health disparities, NHANES, Behavioral Risk Factor Surveillance System
- MeSH terms
- Adolescent, Adult, Aged, Diabetes Mellitus, Female, Health Promotion, Glycated Hemoglobin, Humans, Male, Middle Aged, Nutrition Surveys, Patient Compliance, Risk Factors, Socioeconomic Factors, United States, Body Mass Index, Outcome Assessment, Health Care, Age Distribution, Sex Distribution, Quality Indicators, Health Care, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.